Jan Keltjens Appointed to Board of Directors of AngioDynamics

QUEENSBURY, N.Y.--(Business Wire)--
AngioDynamics, Inc. (NASDAQ:ANGO), a leading provider of innovative medical
devices used by interventional radiologists and surgeons for the
minimally-invasive treatment of cancer and peripheral vascular disease, today
announced Jan Keltjens, 52, President and Chief Executive Officer of the
Company, has been appointed to its Board of Directors. Mr. Keltjens replaces
Eamonn Hobbs, who has resigned from the Board of Directors.

"On behalf of the Board of Directors, I would like to thank Eamonn for all his
contributions to AngioDynamics, both as the company`s co-founder and previous
chief executive officer, as well as most recently as a member of the Board. We
all wish him the very best in his future endeavors," said Vincent Bucci,
Chairman of the Board of Directors. "At the same time, the Board looks forward
to working with Jan in his expanded role with AngioDynamics. During his short
tenure as our president and chief executive officer, his performance has
reinforced the Board`s confidence in his leadership of the Company."

Mr. Keltjens joined AngioDynamics as President and CEO on March 1, 2009. Most
recently, he was President and CEO of CryoCath Technologies, Inc. Mr. Keltjens
also previously served in various leadership positions at Cordis, a Johnson &
Johnson company, including his last position as Worldwide General Manager of
Cordis Neurovascular.

About AngioDynamics

AngioDynamics, Inc. is a leading provider of innovative medical devices used by
interventional radiologists, surgeons and other physicians for the
minimally-invasive treatment of cancer and peripheral vascular disease. The
Company`s diverse product line includes market-leading radiofrequency and
irreversible electroporation ablation systems, vascular access products,
angiographic products and accessories, dialysis products, angioplasty products,
drainage products, thrombolytic products, embolization products and venous
products. More information is available at www.angiodynamics.com.

AngioDynamics, Inc.
D. Joseph Gersuk, CFO, 800-772-6446 ext. 1608
jgersuk@AngioDynamics.com
or
EVC Group, Inc.
Doug Sherk, 415-896-2005 (Investor Relations)
dsherk@evcgroup.com
Jenifer Kirtland, 415-896-2005 (Investor Relations)
jkirtland@evcgroup.com
Chris Gale, 646-201-5431 (Media)
cgale@evcgroup.com
Steve DiMattia, 646-201-5431 (Media)
sdimattia@evcgroup.com

Copyright Business Wire 2009